The Role of Botulinum Toxin A in Treatment of Temporomandibular Joint Disorders: A Review

• Egile Nagusiak: Rana Ataran (Egilea), Ayla Bahramian (Egilea), Zahra Jamali (Egilea), Vahid Pishahang (Egilea), Homayoon Sadeghi Barzegani (Egilea), Parvin Sarbakhsh (Egilea), Javad Yazdani (Egilea)
• Formatua: Liburua
• Argitaratua: Shiraz University of Medical Sciences, 2017-09-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Temporomandibular joint disorders (TMDs) usually present with symptoms and signs such as pain, mandibular movement, dysfunction, or joint sounds. Botulinum toxin type A (BTX-A) is a biologic toxin which inhibits skeletal muscle through hindering the production of acetylcholine in the nerve endings....